ribavirin has been researched along with Lymphoma, Large B-Cell, Diffuse in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bittermann, T; Weinberg, E | 1 |
| Alric, L; Besson, C; Bonnet, D; Cacoub, P; Canioni, D; Davi, F; Hermine, O; Jeannel, J; Lapidus, N; Michot, JM; Pol, S; Rabiega, P; Ysebaert, L | 1 |
| Bodenheimer, HC; Joyce, MA; Kadam, JS; Lake-Bakaar, G; Leonard, J; Lin, A | 1 |
3 other study(ies) available for ribavirin and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Complete Response of Diffuse Large B Cell Lymphoma After Direct-Acting Antiviral Therapy for Hepatitis C Virus.
Topics: Aged; Antiviral Agents; Carbamates; Hepatitis C, Chronic; Heterocyclic Compounds, 4 or More Rings; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Radiography, Abdominal; Ribavirin; Sofosbuvir; Treatment Outcome | 2019 |
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Proportional Hazards Models; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Survival Rate; Treatment Outcome | 2016 |
Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
Topics: Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Ribavirin; Time Factors | 2008 |